Astrana Health, Inc.ASTHEarnings & Financial Report
Nasdaq
NextMar 31, 2026
ASTH Q3 2025 Key Financial Metrics
Revenue
$956.0M
Gross Profit
N/A
Operating Profit
$19.2M
Net Profit
$373.0K
Gross Margin
N/A
Operating Margin
2.0%
Net Margin
0.0%
YoY Growth
99.7%
EPS
$0.01
Financial Flow
Astrana Health, Inc. Q3 2025 Financial Summary
Astrana Health, Inc. reported revenue of $956.0M for Q3 2025, with a net profit of $373.0K (0.0% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $956.0M |
|---|---|
| Net Profit | $373.0K |
| Gross Margin | N/A |
| Operating Margin | 2.0% |
| Report Period | Q3 2025 |
Astrana Health, Inc. Annual Revenue by Year
Astrana Health, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $2.0B).
| Year | Annual Revenue |
|---|---|
| 2024 | $2.0B |
| 2023 | $1.4B |
| 2022 | $1.1B |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $353.0M | $404.4M | $486.3M | $478.7M | $665.2M | $620.4M | $654.8M | $956.0M |
| YoY Growth | 20.0% | 19.9% | 39.6% | 37.5% | 88.4% | 53.4% | 34.7% | 99.7% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $933.4M | $1.23B | $1.25B | $1.29B | $1.35B | $1.33B | $1.44B | $2.24B |
| Liabilities | $522.6M | $773.9M | $773.8M | $778.3M | $840.7M | $813.5M | $904.4M | $1.68B |
| Equity | $614.2M | $653.5M | $678.9M | $704.6M | $712.7M | $745.4M | $765.5M | $775.5M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $19.3M | $6.0M | $23.2M | $34.0M | $-10.9M | $16.6M | $90.9M | $10.0M |